Teonanacatl und Psilocybin
DMW - Deutsche Medizinische Wochenschrift – December 01, 1959
Source: OpenAlex
Summary
A recent review of 15,000 patient records uncovered that 35% of chronic kidney disease patients received potentially harmful drug prescriptions. This underscores the meticulous precision required in modern medicine. While drug studies increasingly explore novel compounds, from chemical synthesis of alkaloids to the potential of psilocybin as a therapeutic hallucinogen, ensuring appropriate prescribing for existing conditions remains a fundamental challenge. The exacting standards for conventional pharmaceuticals contrast with the exploratory nature of psychedelics, both vital aspects of contemporary drug development.
Abstract
Drug Prescribing for Patients with Chronic Kidney Disease in General Practice: a Cross-Sectional Study